Market Analysis and Price Projections for the Drug NDC: 68180-0944
Introduction to the Drug
The drug identified by the National Drug Code (NDC) 68180-0944 is Desoximetasone 0.25% Spray, a topical corticosteroid used to treat various skin conditions such as psoriasis, eczema, and dermatitis. Here, we will delve into the market analysis and price projections for this medication.
Current Market Pricing
As of the latest data, the price of Desoximetasone 0.25% Spray (NDC 68180-0944) has shown some fluctuations. Here are the recent price trends:
- December 2024: $0.81497 per milliliter (ML)[1]
- November 2024: $0.78210 per ML[1]
- October 2024: $0.85784 per ML[1]
- September 2024: $0.80701 per ML[1]
- August 2024: $0.79076 per ML[1]
- July 2024: $0.79076 per ML[1]
These prices indicate a relatively stable market with minor variations.
Overall Pharmaceutical Market Trends
The broader pharmaceutical market provides context for understanding the pricing dynamics of Desoximetasone 0.25% Spray.
Drug Price Inflation
Vizient, Inc. projects a 3.8% increase in drug prices for 2024, driven largely by specialty pharmaceuticals. This is the highest projected increase since July 2019. Specialty drugs, which include treatments for complex conditions like cancer and autoimmune diseases, are expected to see a 4.18% price increase[2].
Impact of Specialty Pharmaceuticals
Specialty pharmaceuticals, which treat high-cost, complex, or chronic conditions, make up a significant portion of the top 15 medications in spend among Vizient pharmacy program participants. The increasing utilization of these drugs, including weight loss medications and gene therapies, is a key driver of the projected price increase[2].
Role of Biosimilars
Biosimilars, which are biologic products that are highly similar to and have no clinically meaningful differences from an existing FDA-approved reference product, are expected to grow in market share. However, their price increase is projected to be minimal at 0.55%. This could potentially impact the pricing of branded drugs as biosimilars gain more market acceptance[2].
Life Sciences Industry Outlook
The life sciences industry is facing several key trends that could influence the pricing and market dynamics of drugs like Desoximetasone 0.25% Spray.
Pricing and Access
C-suite executives in the life sciences industry identify pricing and access to drugs as a significant issue. Nearly half of the executives surveyed expect pricing and access to significantly affect their strategies in 2025[3].
Patent Cliff and Generic Competition
The biopharma industry is facing a substantial loss of exclusivity due to expiring patents on high-revenue products, with over $300 billion in sales at risk through 2030. This could lead to increased competition from generic drugs and biosimilars, potentially affecting the pricing of branded medications[3].
Digital Transformation and Innovation
The integration of technologies like AI and the increased use of data are expected to boost operational efficiencies and drive breakthrough innovations. This could lead to more efficient drug development and potentially lower costs, although the immediate impact on pricing may be limited[3].
US Pharmaceutical Market Growth
The US pharmaceutical market is projected to grow significantly from $846.72 billion in 2022 to $1.28 trillion by 2030, representing a Compound Annual Growth Rate (CAGR) of 5.36%. This growth is driven by factors such as rising workplace-associated disorders, increased pharmaceutical production capacity, and greater approvals of generic drugs[4].
Price Projections for Desoximetasone 0.25% Spray
Given the broader market trends, here are some insights into the potential price projections for Desoximetasone 0.25% Spray:
-
Short-Term Stability: The recent price fluctuations suggest a relatively stable market for Desoximetasone 0.25% Spray in the short term. Prices are likely to remain within the current range of $0.78 to $0.86 per ML.
-
Long-Term Trends: As the pharmaceutical market continues to grow, driven by specialty pharmaceuticals and technological advancements, there could be a slight increase in prices over the long term. However, this increase is likely to be moderate, potentially aligning with the overall 3.8% inflation rate projected by Vizient.
-
Impact of Generic and Biosimilar Competition: If generic or biosimilar versions of Desoximetasone 0.25% Spray become available, this could lead to a decrease in prices due to increased competition.
Key Takeaways
- Current Pricing: Desoximetasone 0.25% Spray prices have shown minor fluctuations, indicating a relatively stable market.
- Market Trends: The broader pharmaceutical market is expected to see a 3.8% price increase driven by specialty pharmaceuticals.
- Life Sciences Outlook: Pricing and access issues, patent expirations, and digital transformation are key trends affecting the life sciences industry.
- US Pharmaceutical Market: The market is projected to grow significantly, driven by various factors including increased approvals of generic drugs.
- Price Projections: Short-term stability with potential for moderate long-term increases, subject to competition from generics and biosimilars.
FAQs
Q: What is the current price of Desoximetasone 0.25% Spray (NDC 68180-0944)?
A: As of December 2024, the price is $0.81497 per milliliter (ML)[1].
Q: What are the key drivers of the projected increase in drug prices for 2024?
A: The increase is driven by specialty pharmaceuticals, including treatments for complex conditions and the increasing utilization of weight loss drugs and gene therapies[2].
Q: How are biosimilars expected to impact the pharmaceutical market?
A: Biosimilars are expected to grow in market share, with a minimal price increase of 0.55%, and could potentially reduce the market share of branded drugs[2].
Q: What are the major trends affecting the life sciences industry in 2025?
A: Pricing and access issues, patent expirations, and digital transformation are significant trends[3].
Q: What is the projected growth of the US pharmaceutical market from 2022 to 2030?
A: The market is projected to grow from $846.72 billion in 2022 to $1.28 trillion by 2030, representing a CAGR of 5.36%[4].
Sources
- DrugPatentWatch - Latest pharmaceutical drug prices and trends for NDC 68180-0944[1]
- Vizient, Inc. - Vizient Projects 3.8% Drug Price Increase Driven by Specialty Pharmaceuticals[2]
- Deloitte Insights - 2025 life sciences outlook[3]
- GlobeNewswire - US Pharmaceutical Market Review 2020-2023 and Forecast 2024-2030[4]
